1a3r:L (VAL3) to (ALA109) FAB FRAGMENT (ANTIBODY 8F5) COMPLEXED WITH PEPTIDE FROM HUMAN RHINOVIRUS (SEROTYPE 2) VIRAL CAPSID PROTEIN VP2 (RESIDUES 156-170) | IMMUNOGLOBULIN, ANTIBODY, RHINOVIRUS, NEUTRALIZATION, CONTINUOUS EPITOPE, COMPLEX (IMMUNOGLOBULIN/VIRAL PEPTIDE), VIRAL PROTEIN/IMMUNE SYSTEM COMPLEX
1a6t:A (GLN1) to (LEU106) FAB FRAGMENT OF MAB1-IA MONOCLONAL ANTIBODY TO HUMAN RHINOVIRUS 14 NIM-IA SITE | IMMUNOGLOBULIN, NEUTRALIZES HUMAN RHINOVIRUS, IGG1
1ad9:A (ASP1) to (VAL106) IGG-FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY CTM01 | IMMUNOGLOBULIN, FAB FRAGMENT
3rvw:C (ILE2) to (MET106) CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1 | ALLERGEN-ANTIBODY COMPLEX, HYDROLASE-IMMUNE SYSTEM COMPLEX
1ap2:A (VAL3) to (PRO112) SINGLE CHAIN FV OF C219 | SINGLE CHAIN FV, MONOCLONAL ANTIBODY, C219, P-GLYCOPROTEIN, IMMUNOGLOBULIN
1nsn:L (VAL3) to (ALA109) THE CRYSTAL STRUCTURE OF ANTIBODY N10-STAPHYLOCOCCAL NUCLEASE COMPLEX AT 2.9 ANGSTROMS RESOLUTION | IMMUNOGLOBULIN, STAPHYLOCOCCAL NUCLEASE, COMPLEX (IMMUNOGLOBULIN/HYDROLASE) COMPLEX
2oz4:L (ILE2) to (ILE106) STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION | IGSF DOMAIN, STRUCTURAL PLASTICITY, CELL-SURFACE DIMERIZATION, CELL ADHESION
4x4x:D (ILE2) to (ILE106) RETROFITTING ANTIBODIES WITH STABILIZING MUTATIONS. HERCEPTIN SCFV MUTANT. | ANTIBODY STABILIZATION MUTATIONS, IMMUNE SYSTEM
4x4y:B (ILE2) to (ILE106) RETROFITTING ANTIBODIES WITH STABILIZING MUTATIONS. HERCEPTIN SCFV MUTANT K30D/S52D. | ANTIBODY STABILIZATION MUTATIONS, IMMUNE SYSTEM
1bql:L (VAL3) to (ILE104) STRUCTURE OF AN ANTI-HEL FAB FRAGMENT COMPLEXED WITH BOBWHITE QUAIL LYSOZYME | ANTIBODY/ANTIGEN COMPLEX, HYHEL-5, ANTI-LYSOZYME, BOBWHITE QUAIL
2bx5:K (ILE2) to (ILE106) IS FR1 THE ANTIBODY'S ACHILLIES HEEL | IMMUNE SYSTEM, AMYLOID, LCDD, ANTIBODY, AGGREGATION, FR1
1c1e:L (LEU2) to (GLU105) CRYSTAL STRUCTURE OF A DIELS-ALDERASE CATALYTIC ANTIBODY 1E9 IN COMPLEX WITH ITS HAPTEN | CATALYTIC ANTIBODY, DIELS-ALDER, IMMUNOGLOBULIN, IMMUNE SYSTEM
3se8:L (GLU1) to (VAL106) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC03 IN COMPLEX WITH HIV-1 GP120 | HIV, GP120, ANTIBODY, VRC03, NEUTRALIZATION, VACCINE, ENVELOPE GLYCOPROTEIN, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4xhj:G (GLN3) to (ILE106) GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES. | COMPLEX, NEUTRALIZATION EPITOPES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1osp:L (ILE2) to (ALA109) CRYSTAL STRUCTURE OF OUTER SURFACE PROTEIN A OF BORRELIA BURGDORFERI COMPLEXED WITH A MURINE MONOCLONAL ANTIBODY FAB | COMPLEX (IMMUNOGLOBULIN-LIPOPROTEIN), OUTER SURFACE PROTEIN A COMPLEXED WITH FAB184.1, BORRELIA BURGDORFERI STRAIN B31, COMPLEX (IMMUNOGLOBULIN-LIPOPROTEIN) COMPLEX
2q1e:A (ILE2) to (ILE106) ALTERED DIMER INTERFACE DECREASES STABILITY IN AN AMYLOIDOGENIC KAPPA1 BENCE JONES PROTEIN. | AL, LIGHT CHAIN AMYLOIDOSIS, AMYLOID, IMMUNOGLOBULIN, LIGHT CHAIN, LIGHT CHAIN VARIABLE DOMAIN, PROTEIN FIBRIL
2q1e:B (GLN3) to (ILE106) ALTERED DIMER INTERFACE DECREASES STABILITY IN AN AMYLOIDOGENIC KAPPA1 BENCE JONES PROTEIN. | AL, LIGHT CHAIN AMYLOIDOSIS, AMYLOID, IMMUNOGLOBULIN, LIGHT CHAIN, LIGHT CHAIN VARIABLE DOMAIN, PROTEIN FIBRIL
2q1e:C (GLN3) to (LYS107) ALTERED DIMER INTERFACE DECREASES STABILITY IN AN AMYLOIDOGENIC KAPPA1 BENCE JONES PROTEIN. | AL, LIGHT CHAIN AMYLOIDOSIS, AMYLOID, IMMUNOGLOBULIN, LIGHT CHAIN, LIGHT CHAIN VARIABLE DOMAIN, PROTEIN FIBRIL
2q1e:D (ILE2) to (ILE106) ALTERED DIMER INTERFACE DECREASES STABILITY IN AN AMYLOIDOGENIC KAPPA1 BENCE JONES PROTEIN. | AL, LIGHT CHAIN AMYLOIDOSIS, AMYLOID, IMMUNOGLOBULIN, LIGHT CHAIN, LIGHT CHAIN VARIABLE DOMAIN, PROTEIN FIBRIL
2q76:C (ILE2) to (ILE106) MOUSE ANTI-HEN EGG WHITE LYSOZYME ANTIBODY F10.6.6 FAB FRAGMENT | ANTIBODY, FAB FRAGMENT, LYSOZYME, AFFINITY MATURATION, VH- VL INTERFACE., IMMUNE SYSTEM
1d5i:L (ILE2) to (ILE106) UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY | IMMUNE SYSTEM
4xp6:L (ASN2) to (MET107) X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER BOUND TO PSYCHOSTIMULANT METHAMPHETAMINE | INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, TRANPORT PROTEIN-INHIBITOR COMPLEX
4xpg:L (VAL3) to (MET107) X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO BETA-CFT OR WIN35428 | ALL ALPHA-HELICAL INTEGRAL MEMBRANE PROTEIN, TRANSPORT PROTEIN- INHIBITOR COMPLEX
3g5x:A (LEU3) to (ILE106) ANTIBODIES SPECIFICALLY TARGETING A LOCALLY MISFOLDED REGION OF TUMOR ASSOCIATED EGFR | ANTIBODY, IMMUNE SYSTEM
3g6j:E (ILE2) to (THR109) C3B IN COMPLEX WITH A C3B SPECIFIC FAB | COMPLEMENT, C3B, FAB, ANTIBODY:ANTIGEN, AGE-RELATED MACULAR DEGENERATION, CLEAVAGE ON PAIR OF BASIC RESIDUES, COMPLEMENT ALTERNATE PATHWAY, COMPLEMENT PATHWAY, DISEASE MUTATION, GLYCOPROTEIN, IMMUNE RESPONSE, INFLAMMATORY RESPONSE, INNATE IMMUNITY, PHOSPHOPROTEIN, SECRETED, THIOESTER BOND, IMMUNE SYSTEM
2qqk:L (ASP1) to (THR109) NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB | VEGF RECEPTOR, SEMAPHORIN RECEPTOR, PHAGE-DERIVED ANTIBODY, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, GLYCOPROTEIN, MEMBRANE, NEUROGENESIS, TRANSMEMBRANE, HORMONE, SIGNALING PROTEIN
1dzb:A (ILE202) to (ILE306) CRYSTAL STRUCTURE OF PHAGE LIBRARY-DERIVED SINGLE-CHAIN FV FRAGMENT 1F9 IN COMPLEX WITH TURKEY EGG-WHITE LYSOZYME | IMMUNE SYSTEM, COMPLEX (ANTIBODY ANTIGEN), SINGLE-DOMAIN ANTIBODY, TURKEY EGG-WHITE LYSOZYME, ANTIBODY- PROTEIN COMPLEX, SINGLE-CHAIN FV FRAGMENT
1dzb:B (ILE202) to (ILE306) CRYSTAL STRUCTURE OF PHAGE LIBRARY-DERIVED SINGLE-CHAIN FV FRAGMENT 1F9 IN COMPLEX WITH TURKEY EGG-WHITE LYSOZYME | IMMUNE SYSTEM, COMPLEX (ANTIBODY ANTIGEN), SINGLE-DOMAIN ANTIBODY, TURKEY EGG-WHITE LYSOZYME, ANTIBODY- PROTEIN COMPLEX, SINGLE-CHAIN FV FRAGMENT
4j1u:A (ILE2) to (SER114) CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT | ANTIBODY MATURATION, ANTIBODY STABILITY, CLONAL SELECTION, IMMUNE SYSTEM
2r56:L (VAL3) to (ILE106) CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN | ALLERGEN, IGE, EPITOPE, IMMUNOCOMPLEX, LIPOCALIN, FAB, MILK PROTEIN, POLYMORPHISM, RETINOL-BINDING, SECRETED, TRANSPORT, IMMUNE SYSTEM
2r56:M (VAL3) to (THR109) CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN | ALLERGEN, IGE, EPITOPE, IMMUNOCOMPLEX, LIPOCALIN, FAB, MILK PROTEIN, POLYMORPHISM, RETINOL-BINDING, SECRETED, TRANSPORT, IMMUNE SYSTEM
4jha:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25 | IMMUNOGLOBULIN, IG, IMMUNE SYSTEM
2dwd:B (ASP1) to (ILE106) CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN TL+ | POTASSIUM CHANNEL, MEMBRANE PROTEIN, TETRABUTYLAMMONIUM, K+, KCSA
4jm4:L (VAL3) to (THR109) CRYSTAL STRUCTURE OF PGT 135 FAB | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM
3h3b:D (ILE2) to (ILE112) CRYSTAL STRUCTURE OF THE SINGLE-CHAIN FV (SCFV) FRAGMENT OF AN ANTI- ERBB2 ANTIBODY CHA21 IN COMPLEX WITH RESIDUES 1-192 OF ERBB2 EXTRACELLULAR DOMAIN | IMMUNOGLOBULIN, BETA-HELIX, PROTEIN-PROTEIN COMPLEX, ATP-BINDING, DISULFIDE BOND, KINASE, NUCLEOTIDE-BINDING, RECEPTOR, TRANSFERASE, TRANSMEMBRANE, TYROSINE-PROTEIN KINASE, IMMUNE SYSTEM
4jpi:L (ILE2) to (ILE108) CRYSTAL STRUCTURE OF A PUTATIVE VRC01 GERMLINE PRECURSOR FAB | ANTI-HIV-1, GP120, CD4 BINDING SITE-TARGETING, VRC01 BROADLY NEUTRALIZING ANTIBODY, IMMUNE SYSTEM
1qp1:C (ILE2) to (ILE106) KAPPA VARIABLE LIGHT CHAIN | BETA SANDWICH, DOUBLE SPIRAL, IMMUNE SYSTEM
3hb3:D (ILE2) to (ILE107) HIGH RESOLUTION CRYSTAL STRUCTURE OF PARACOCCUS DENITRIFICANS CYTOCHROME C OXIDASE | ELECTRON TRANSFER, PROTON TRANSFER, PROTON PUMPING, MEMBRANE PROTEIN, CELL INNER MEMBRANE, CELL MEMBRANE, COPPER, DISULFIDE BOND, ELECTRON TRANSPORT, HEME, HYDROGEN ION TRANSPORT, ION TRANSPORT, IRON, MEMBRANE, METAL-BINDING, OXIDOREDUCTASE, RESPIRATORY CHAIN, TRANSMEMBRANE, TRANSPORT, PYRROLIDONE CARBOXYLIC ACID
3u7a:A (ASP1) to (ILE106) AL-09 Y32F Y96F | IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN, IMMUNE SYSTEM
3hfm:L (ILE2) to (ALA109) STRUCTURE OF AN ANTIBODY-ANTIGEN COMPLEX. CRYSTAL STRUCTURE OF THE HY/HEL-10 FAB-LYSOZYME COMPLEX | COMPLEX(ANTIBODY-ANTIGEN)
2exw:D (ILE2) to (ILE105) CRYSTAL STRUCTURE OF A ECCLC-FAB COMPLEX IN THE ABSENCE OF BOUND IONS | CLC FAMILY OF CL- CHANNELS AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN/FAB COMPLEX
1rei:A (GLN3) to (ILE106) THE MOLECULAR STRUCTURE OF A DIMER COMPOSED OF THE VARIABLE PORTIONS OF THE BENCE-JONES PROTEIN REI REFINED AT 2.0 ANGSTROMS RESOLUTION | IMMUNOGLOBULIN(PART)SEQUESTERS ANTIGENS
1rhh:A (GLU1) to (THR108) CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION | FAB, ANTIBODY, X5, HIV-1, BROADLY NEUTRALIZING, IMMUNE SYSTEM
1rhh:C (LEU2) to (THR108) CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION | FAB, ANTIBODY, X5, HIV-1, BROADLY NEUTRALIZING, IMMUNE SYSTEM
1rih:L (LEU2) to (LEU106) CRYSTAL STRUCTURE OF FAB 14F7, A UNIQUE ANTI-TUMOR ANTIBODY SPECIFIC FOR N-GLYCOLYL GM3 | ANTIBODY, CARBOHYDRATE-BINDING FAB, SPECIFIC FOR NEUGC-GM3, IMMUNOGLOBULIN, BETA-SHEET TOPOLOGY, IMMUNE SYSTEM
3hmx:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF USTEKINUMAB FAB/IL-12 COMPLEX | USTEKINUMAB, CNTO1275, IL-12, IL-23, ANTIBODY, FAB, MONOCLONAL ANTIBODY, IMMUNE SYSTEM, CYTOKINE, DISULFIDE BOND, GLYCOPROTEIN, IMMUNOGLOBULIN DOMAIN, SECRETED, GROWTH FACTOR, CYTOKINE-MMUNE SYSTEM COMPLEX, CYTOKINE-IMMUNE SYSTEM COMPLEX
1rz8:A (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rz8:C (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzg:B (GLN3) to (ILE106) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzi:I (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1rzi:O (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB | HIV-1; GP120; CD4I; ANTIBODIES; TYROSINE SULFATION; VH-GENE USAGE, IMMUNE SYSTEM
1sbs:L (VAL3) to (ALA115) CRYSTAL STRUCTURE OF AN ANTI-HCG FAB | MONOCLONAL ANTIBODY, FAB-FRAGMENT, REPRODUCTION
4kro:C (ASP1) to (THR109) NANOBODY/VHH DOMAIN EGA1 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR | CELL SURFACE RECEPTOR, GLYCOPROTEIN, NANOBODY, VHH DOMAIN, CAMELID VH DOMAIN, ANTIBODY, ANTIGEN, ANTIBODY COMPLEX, TRANSFERASE-IMMUNE SYSTEM COMPLEX
4krp:C (ILE2) to (THR109) NANOBODY/VHH DOMAIN 9G8 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR | CELL SURFACE RECEPTOR, GLYCOPROTEIN, NANOBODY, VHH DOMAIN, CAMELID VH DOMAIN, ANTIBODY, ANTIGEN, ANTIBODY COMPLEX, TRANSFERASE-IMMUNE SYSTEM COMPLEX
4ktd:L (VAL3) to (VAL106) FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY, GE136, FROM NON-HUMAN PRIMATE | ANTIBODY AFFINITY, ANTIBODY SPECIFICITY, VACCINE ELICITED ANTIBODIES, FAB FRAGMENT, AIDS VACCINES, IMMUNE SYSTEM
4kuc:D (ASP21) to (ILE125) CRYSTAL STRUCTURE OF RICIN-A CHAIN IN COMPLEX WITH THE ANTIBODY 6C2 | RNA-N-GLYCOSIDASE, HYDROLASE-IMMUNE SYSTEM COMPLEX
3vg0:L (GLU3) to (ALA111) ANTIBODY FAB FRAGMENT | ANTIBODY FAB FRAGMENT, IMMUNOGLOBULIN FOLD, N-LINKED GLYCOSYLATION SITE, FAB FRAGMENT, LBD DOMAIN OF OBR RECEPTOR, IMMUNE SYSTEM
1t04:A (ASP1) to (VAL106) THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB IN C2 SPACE GROUP | ANTIBODY ENGINEERING, HUMANIZED AND CHIMERIC ANTIBODY, FAB, X-RAY STRUCTURE, THREE-DIMENSIONAL STRUCTURE, GAMMA- INTERFERON, IMMUNE SYSTEM
1t4k:C (ASP1) to (LEU106) CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB | ENANTIOSELECTIVITY, ALDOLASE ANTIBODY, REACTIVE LYSINE, ALDOL REACTION, IMMUNE SYSTEM
4laq:L (VAL3) to (ILE106) CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE | METHAMPHETAMINE, ANTI-METHAMPHETAMINE ANTIBODY, THERAPEUTIC ANTIBODY, SCFV, IMMUNE SYSTEM
1hh9:A (ILE2) to (LEU106) ANTI-P24 (HIV-1) FAB FRAGMENT CB41 COMPLEXED WITH A PEPTIDE | IMMUNE SYSTEM/PEPTIDE, COMPLEX (ANTIBODY/PEPTIDE), POLYSPECIFICITY, CROSSREACTIVITY, FAB-FRAGMENT, PEPTIDE, HIV-1
4zyk:L (GLN3) to (THR109) CRYSTAL STRUCTURE OF QUATERNARY-SPECIFIC RSV-NEUTRALIZING HUMAN ANTIBODY AM14 | IG DOMAIN, FAB, IMMUNE SYSTEM
4lkc:A (ALA2) to (ILE107) AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO | IMMUNOGLOBULIN, ANTIBODY, PCSK9, IMMUNE SYSTEM
3ixt:L (ASP1) to (ILE106) CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE | FAB, RSV, SYNAGIS, MOTAVIZUMAB, MONOCLONAL, COMPLEX, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, LIPOPROTEIN, MEMBRANE, PALMITATE, TRANSMEMBRANE, VIRION, IMMUNE SYSTEM
3ixt:B (ASP1) to (ILE106) CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE | FAB, RSV, SYNAGIS, MOTAVIZUMAB, MONOCLONAL, COMPLEX, CELL MEMBRANE, CLEAVAGE ON PAIR OF BASIC RESIDUES, DISULFIDE BOND, ENVELOPE PROTEIN, FUSION PROTEIN, GLYCOPROTEIN, LIPOPROTEIN, MEMBRANE, PALMITATE, TRANSMEMBRANE, VIRION, IMMUNE SYSTEM
5a16:B (ASP1) to (ILE110) CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1 | IMMUNE SYSTEM, FAB FRAGMENT, ANION EXCHANGER
5a16:D (ASP1) to (ILE110) CRYSTAL STRUCTURE OF FAB4201 RAISED AGAINST HUMAN ERYTHROCYTE ANION EXCHANGER 1 | IMMUNE SYSTEM, FAB FRAGMENT, ANION EXCHANGER
4lrn:L (VAL3) to (ILE106) ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV ANTIBODY 4E10 | GERMLINE, HIV, IMMUNOGLOBULIN, FV PORTION OF AB, 4E10 EPITOPE, IMMUNE SYSTEM
2htk:D (ASP1) to (ILE105) STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445A MUTANT AND FAB COMPLEX | CLC FAMILY OF CHANNEL AND TRANSPORTERS, H+/CL- ANTIPORTER, MEMBRANE PROTEIN, FAB COMPLEX
1igm:L (GLN3) to (ILE106) THREE DIMENSIONAL STRUCTURE OF AN FV FROM A HUMAN IGM IMMUNOGLOBULIN | IMMUNOGLOBULIN
4ma3:A (PCA1) to (VAL111) CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095 | IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNE SYSTEM
1ivl:A (ILE2) to (ILE106) THE DE NOVO DESIGN OF AN ANTIBODY COMBINING SITE: CRYSTALLOGRAPHIC ANALYSIS OF THE VL DOMAIN CONFIRMS THE STRUCTURAL MODEL | IMMUNOGLOBULIN
3wfc:L (GLN3) to (LEU106) REDUCED AND CARBONMONOXIDE-BOUND CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT | METAL-BINDING, MEMBRANE PROTEIN, IMMUNE SYSTEM-OXIDOREDUCTASE COMPLEX
2imm:A (ILE2) to (LEU106) REFINED CRYSTAL STRUCTURE OF A RECOMBINANT IMMUNOGLOBULIN DOMAIN AND A COMPLEMENTARITY-DETERMINING REGION 1-GRAFTED MUTANT | IMMUNOGLOBULIN
1v7m:M (VAL2) to (ILE105) HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB | THROMBOPOIETIN, FAB FRAGMENT, COMPLEX (CYTOKINE/ANTIBODY), IMMUNE SYSTEM/CYTOKINE COMPLEX
2j4w:L (VAL3) to (ILE106) STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1- FAB F8.12.19 COMPLEX | IMMUNOGLOBULIN DOMAIN, IMMUNOGLOBULIN C REGION, MEMBRANE, TRANSMEMBRANE, HYPOTHETICAL PROTEIN, ANTIBODY CROSS- REACTIVITY, SURFACE ACTIVE PROTEIN, MALARIA VACCINE CANDIDATE, APICAL MEMBRANE ANTIGEN 1, IMMUNE SYSTEM
2j5l:B (VAL3) to (ALA109) STRUCTURE OF A PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX | MALARIA VACCINE CANDIDATE, APICAL MEMBRANE ANTIGEN 1, HYPOTHETICAL PROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, MEROZOITE, TRANSMEMBRANE, IMMUNE SYSTEM, IMMUNOGLOBULIN C REGION, ANTIBODY CROSS-REACTIVITY
1jnh:C (GLN1) to (VAL108) CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES | IGG FOLD, ANTIBODY-HAPTEN COMPLEX, ESTRADIOL, IMMUNE SYSTEM
4mwf:L (GLU3) to (ILE106) STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C | IMMUNOGLOBULIN FOLD, HCV E2, IMMUNE SYSTEM
4mxv:X (ILE2) to (ILE106) STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB | TNF, TUMOR NECROSIS FACTOR, TNFR RECEPTOR, LYMPHOTOXIN BETA RECEPTOR, LYMPHOTOXIN ALPHA, LYMPHOID DEVELOPMENT, TUMOR IMMUNITY, AUTO- IMMUNITY, CYTOKINE-IMMUNE SYSTEM COMPLEX
4n1e:B (ILE2) to (ILE106) STRUCTURAL EVIDENCE FOR ANTIGEN RECEPTOR EVOLUTION | IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN, ANTIGEN-RECEPTOR INTERACTION, IG-FOLD, IMMUNE SYSTEM-HYDROLASE COMPLEX
5b8c:A (GLU1) to (ILE110) HIGH RESOLUTION STRUCTURE OF THE HUMAN PD-1 IN COMPLEX WITH PEMBROLIZUMAB FV | ANTIBODY, IMMUNE SYSTEM
4n8c:L (ILE2) to (LEU112) THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS | ANTIBODY-PEPTIDE COMPLEX, INFLUENZA A VIRUS PROTEIN, IMMUNE SYSTEM
4n8c:M (ILE2) to (LEU112) THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS | ANTIBODY-PEPTIDE COMPLEX, INFLUENZA A VIRUS PROTEIN, IMMUNE SYSTEM
4n90:E (ILE2) to (THR110) CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL, DR5, AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY | DR5, TRAIL, AGONIST, ANTIBODY, COOPERATION, CLUSTERING, APOPTOSIS- IMMUNE SYSTEM COMPLEX
1wcb:A (GLU3) to (ALA109) PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN | CATALYTIC ANTIBODY, TRANSAMINATION, PYRIDOXAL-PHOSPHATE, HAPTEN, PHOSPHOPYRIDOXYL-L-LYSINE, IMMUNE SYSTEM
1k6q:L (ILE2) to (LEU106) CRYSTAL STRUCTURE OF ANTIBODY FAB FRAGMENT D3 | ANTIGEN-ANTIBODY RECOGNITION, CRYSTAL STRUCTURE, BLOOD COAGULATION, TISSUE FACTOR, IMMUNE SYSTEM
5bvj:A (ILE2) to (ILE106) THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB, A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA | IMMUNOGLOBULIN, FAB, IMMUNE SYSTEM
5bvj:C (VAL3) to (ILE106) THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB, A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA | IMMUNOGLOBULIN, FAB, IMMUNE SYSTEM
5bvj:E (VAL3) to (ILE106) THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB, A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA | IMMUNOGLOBULIN, FAB, IMMUNE SYSTEM
5bvj:G (VAL3) to (ILE106) THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB, A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA | IMMUNOGLOBULIN, FAB, IMMUNE SYSTEM
1kc5:L (VAL3) to (LEU106) CRYSTAL STRUCTURE OF ANTIBODY PC287 IN COMPLEX WITH PS1 PEPTIDE | ANTIBODY, PEPTIDE ANTIGEN, COMPLEX (ANTIBODY/PEPTIDE), IMMUNE SYSTEM
1kcv:L (ASP1) to (LEU106) CRYSTAL STRUCTURE OF ANTIBODY PC282 | ANTI-PEPTIDE ANTIBODY, FAB FRAGMENT, IMMUNE SYSTEM
5bzd:A (GLU1) to (THR109) CRYSTAL STRUCTURE OF PCDN-27A, AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES | HIV, ANTIBODY, FAB, IMMUNE SYSTEM
5bzd:C (GLU1) to (THR109) CRYSTAL STRUCTURE OF PCDN-27A, AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES | HIV, ANTIBODY, FAB, IMMUNE SYSTEM
2lve:A (VAL3) to (ILE106) RECOMBINANT LEN | IMMUNOGLOBULIN, KAPPA-IV, LIGHT CHAIN DIMER
2yc1:B (ILE134) to (ILE238) CRYSTAL STRUCTURE OF THE HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 9004G IN COMPLEX WITH CN2 TOXIN FROM THE SCORPION CENTRUROIDES NOXIUS HOFFMANN | IMMUNE SYSTEM-TOXIN COMPLEX, SCORPION TOXIN
2yc1:E (ILE134) to (ILE238) CRYSTAL STRUCTURE OF THE HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENT (SCFV) 9004G IN COMPLEX WITH CN2 TOXIN FROM THE SCORPION CENTRUROIDES NOXIUS HOFFMANN | IMMUNE SYSTEM-TOXIN COMPLEX, SCORPION TOXIN
3ztj:J (ILE2) to (ILE106) STRUCTURE OF INFLUENZA A NEUTRALIZING ANTIBODY SELECTED FROM CULTURES OF SINGLE HUMAN PLASMA CELLS IN COMPLEX WITH HUMAN H3 INFLUENZA HAEMAGGLUTININ. | IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX, X31, MONOCLONAL ANTIBODY
4nrx:B (GLN3) to (THR109) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE | IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM
4nrx:E (ILE2) to (THR109) CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE | IMMUNOGLOBULIN, NEUTRALIZING ANTIBODY, HIV-1 GP41, MEMBRANE PROXIMAL EXTERNAL REGION, MPER, IMMUNE SYSTEM
4nyl:D (ILE2) to (ILE106) CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT | IMMUNOGLOBULIN FOLDING, ANTIBODY FRAGMENT, TNF ALPHA, IMMUNE SYSTEM
4nzr:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-HIV ANTIBODY PGT135 FAB | LEUCINE-RICH REPEAT, BROAD ANTIBODY-BINDING, BLOCK ANTIBODY-ANTIGEN UNION, VARIABLE REGION, IMMUNE SYSTEM-PROTEIN BINDING COMPLEX
1xf5:A (ILE2) to (LEU112) COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C, Y64W)IN SPACE GROUP P21212 | CRYSTAL PACKING, FAB, PROTEIN L, PEPTIDE COMPLEX, IMMUNE SYSTEM
43ca:E (VAL3) to (LYS107) CRYSTALLOGRAPHIC STRUCTURE OF THE ESTEROLYTIC AND AMIDOLYTIC 43C9 ANTIBODY WITH BOUND P-NITROPHENOL | IMMUNOGLOBULIN, CATALYTIC ANTIBODY
2ymx:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF INHIBITORY ANTI-ACHE FAB408 | IMMUNE SYSTEM, ACETYLCHOLINESTERASE, INHIBITION, BACK DOOR REGION
5cd3:H (GLN3) to (ILE108) STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7 | VRC01, HIV-1, CD4 BINDING SITE, GP120, IMMUNE SYSTEM
5cd3:D (ILE2) to (ILE108) STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7 | VRC01, HIV-1, CD4 BINDING SITE, GP120, IMMUNE SYSTEM
2ypv:L (VAL3) to (ILE106) CRYSTAL STRUCTURE OF THE MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN IN COMPLEX WITH A BACTERICIDAL ANTIBODY | IMMUNE SYSTEM, VACCINE, MONOCLONAL ANTIBODY, MAB, EPITOPE MAPPING
4of8:D (ALA31) to (PRO131) CRYSTAL STRUCTURE OF RST D1-D2 | IMMUNOGLOBULIN SUPERFAMILY, CELL ADHESION, MYOBLAST FUSION, EYE DEVELOPMENT, PROTEIN BINDING, MEMBRANE, EXTRACELLULAR, SIGNALING PROTEIN
5cma:A (ILE2) to (THR109) ANTI-B7-H3 MONOCLONAL ANTIBODY CH8H9 FAB FRAGMENT | B7-H3 8H9 MONOCLONAL ANTIBODY, IMMUNE SYSTEM
4oii:L (ASP1) to (ILE106) WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB | WEST NILE VIRUS, ANTIBODY, FAB, NEUTRALIZING, FLAVIVIRUS, NON- STRUCTURAL PROTEIN, NS1, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID
4oii:M (ASP1) to (ILE106) WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB | WEST NILE VIRUS, ANTIBODY, FAB, NEUTRALIZING, FLAVIVIRUS, NON- STRUCTURAL PROTEIN, NS1, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID
4otx:L (GLN1) to (ALA109) STRUCTURE OF THE ANTI-FRANCISELLA TULARENSIS O-ANTIGEN ANTIBODY N203 FAB FRAGMENT | ANTIBODY, IMMUNE SYSTEM, LIPOPOLYSACCHARIDE, INTERNAL EPITOPE
1mcq:A (PRO1) to (GLY111) PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS | IMMUNOGLOBULIN
4oz4:L (VAL3) to (ILE111) X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A. | FAB, APO-FORM, IMMUNE SYSTEM
4oz4:B (VAL3) to (ALA114) X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A. | FAB, APO-FORM, IMMUNE SYSTEM
3kym:O (GLN3) to (ILE106) CRYSTAL STRUCTURE OF LI33 IGG2 DI-FAB | IGG2 MONOCLONAL ANTI-LINGO, IMMUNE SYSTEM
3l1o:L (GLN3) to (LEU106) CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MN423 FAB FRAGMENT WITH FREE COMBINING SITE, CRYSTALLIZED IN THE PRESENCE OF ZINC | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3l7e:A (ASP1) to (THR109) CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836 | IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3l95:A (GLN3) to (ILE106) CRYSTAL STRUCTURE OF THE HUMAN NOTCH1 NEGATIVE REGULATORY REGION (NRR) BOUND TO THE FAB FRAGMENT OF AN ANTAGONIST ANTIBODY | NRR, FAB FRAGMENT, ANTIBODY, ALPHA-BETA-SANDWICH, SEA DOMAIN, LNR, LIN12 NOTCH CYSTEINE-RICH, HD DOMAIN, CELL CYCLE, SIGNALING PROTEIN, ACTIVATOR, ANK REPEAT, CELL MEMBRANE, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, EGF-LIKE DOMAIN, GLYCOPROTEIN, MEMBRANE, METAL- BINDING, NOTCH SIGNALING PATHWAY, IMMUNE SYSTEM
3l95:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF THE HUMAN NOTCH1 NEGATIVE REGULATORY REGION (NRR) BOUND TO THE FAB FRAGMENT OF AN ANTAGONIST ANTIBODY | NRR, FAB FRAGMENT, ANTIBODY, ALPHA-BETA-SANDWICH, SEA DOMAIN, LNR, LIN12 NOTCH CYSTEINE-RICH, HD DOMAIN, CELL CYCLE, SIGNALING PROTEIN, ACTIVATOR, ANK REPEAT, CELL MEMBRANE, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, EGF-LIKE DOMAIN, GLYCOPROTEIN, MEMBRANE, METAL- BINDING, NOTCH SIGNALING PATHWAY, IMMUNE SYSTEM
4am0:B (ASP1) to (ALA109) STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12 | VIRAL PROTEIN, ANTIBODY, NEUTRALISATION
4am0:D (ASP1) to (ALA109) STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12 | VIRAL PROTEIN, ANTIBODY, NEUTRALISATION
4am0:F (ASP1) to (ALA109) STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12 | VIRAL PROTEIN, ANTIBODY, NEUTRALISATION
4am0:L (ASP1) to (ALA109) STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12 | VIRAL PROTEIN, ANTIBODY, NEUTRALISATION
3ldb:B (ASP1) to (ALA115) STRUCTURE OF JMJD6 COMPLEXD WITH ALPHA-KETOGLUTARATE AND FAB FRAGMENT. | JMJ6D, ALPHA-KETOGLUTARATE, FAB FRAGMENTS, IMMUNE SYSTEM
1za6:A (VAL3) to (THR115) THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY | IMMUNOGLOBULIN FOLD, CH2-DOMAIN-DELETION, IMMUNE SYSTEM
1za6:C (VAL3) to (THR115) THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY | IMMUNOGLOBULIN FOLD, CH2-DOMAIN-DELETION, IMMUNE SYSTEM
1za6:E (ASP1) to (THR115) THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY | IMMUNOGLOBULIN FOLD, CH2-DOMAIN-DELETION, IMMUNE SYSTEM
1za6:G (ASP1) to (LEU112) THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY | IMMUNOGLOBULIN FOLD, CH2-DOMAIN-DELETION, IMMUNE SYSTEM
5drz:A (LEU3) to (THR109) CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE | IGG, VIRAL PROTEIN, HIV GP41 ENVELOPE PROTEIN, IMMUNE SYSTEM
4py7:B (GLN3) to (ILE106) CRYSTAL STRUCTURE OF FAB 3.1 | IMMUNOGLOBULIN FAB FRAGMENT, NEUTRALIZING ANTIBODY, HEMAGGLUTININ GLYCOPROTEINS, IMMUNE SYSTEM
1zlv:K (VAL2) to (ILE106) FAB 2G12 + MAN7 | HIV NEUTRALIZING ANTIBODY; ANTI-CARBOHYDRATE; DOMAIN- SWAPPING, IMMUNE SYSTEM
5ebl:B (ILE2) to (ILE106) KCSA T75G IN THE CONDUCTIVE STATE | ALPHA-HELICAL, MEMBRANE PROTEIN, FAB, CHANNEL
5ebm:B (ILE2) to (ALA109) KCSA T75G MUTANT IN THE NONCONDUCTIVE STATE | ALPHA-HELICAL, MEMBRANE PROTEIN, FAB, CHANNEL
3mbx:L (ILE2) to (ALA115) CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY X836 | IMMUNOGLOBULIN FOLD, MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3bd4:A (LEU160) to (ILE270) CRYSTAL STRUCTURE OF SINGLE DOMAIN VL OF AN ANTI-DNA BINDING ANTIBODY 3D8 SCFV AND ITS ACTIVE SITE REVEALED BY COMPLEX STRUCTURES OF A SMALL MOLECULE AND METALS | BETA SANDWICH, METAL, IMMUNE SYSTEM
3bd5:B (LEU160) to (ILE270) CRYSTAL STRUCTURE OF SINGLE DOMAIN VL OF AN ANTI-DNA BINDING ANTIBODY 3D8 SCFV AND ITS ACTIVE SITE REVEALED BY COMPLEX STRUCTURES OF A SMALL MOLECULE AND METALS | BETA SANDWICH, METAL COMPLEX, IMMUNE SYSTEM
4qt5:L (GLU3) to (LEU106) CRYSTAL STRUCTURE OF 3BD10: A MONOCLONAL ANTIBODY AGAINST THE TSH RECEPTOR | GRAVES DISEASE, ANTIBODY, TSH RECEPTOR, THYROID, IMMUNE SYSTEM
3bky:L (VAL3) to (THR108) CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY C2H7 FAB IN COMPLEX WITH A CD20 PEPTIDE | 2H7, C2H7, CHIMERIC ANTIBODY, FAB, CD20, FAB-PEPTIDE COMPLEX, B-CELL ACTIVATION, MEMBRANE, PHOSPHOPROTEIN, TRANSMEMBRANE, IMMUNE SYSTEM
3mxw:L (ILE2) to (THR109) CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT | ANTIBODY COMPLEX, FAB FRAGMENT, METALLOPROTEASE, CALCIUM BINDING, ZINC HYDROLASE, DEVELOPMENT, MORPHOGEN, SIGNALING PROTEIN
5f88:A (ILE2) to (THR109) CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
4r7d:J (ILE2) to (ILE106) FAB HU 15C1 | TLR4 ANTIBODY, IMMUNE SYSTEM
4r7n:J (VAL3) to (THR109) FAB C2E3 | TLR4 ANTIBODY, IMMUNE SYSTEM
4r7n:N (ILE2) to (THR109) FAB C2E3 | TLR4 ANTIBODY, IMMUNE SYSTEM
4r7n:P (VAL3) to (ILE106) FAB C2E3 | TLR4 ANTIBODY, IMMUNE SYSTEM
3nab:L (GLN3) to (ILE106) CRYSTAL STRUCTURE OF FAB15 MUT6 | ANTIBODY, ANTIBODY CANONICAL STRUCTURE, THERMAL STABILITY, NON-X-PRO CIS PEPTIDE BOND, ANTIBODY ENGINEERING, IMMUNE SYSTEM
3cdc:A (ILE2) to (ILE106) KI O18/O8 N34I/Y87H IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN | GREEK KEY BETA BARREL, AMYLOID, IMMUNOGLOBULIN, LIGHT CHAIN, VARIABLE DOMAIN, IMMUNE SYSTEM
4cc8:J (GLU1) to (VAL106) PRE-FUSION STRUCTURE OF TRIMERIC HIV-1 ENVELOPE GLYCOPROTEIN DETERMINED BY CRYO-ELECTRON MICROSCOPY | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, PRE-FUSION STATE
4cc8:K (GLU1) to (VAL106) PRE-FUSION STRUCTURE OF TRIMERIC HIV-1 ENVELOPE GLYCOPROTEIN DETERMINED BY CRYO-ELECTRON MICROSCOPY | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, PRE-FUSION STATE
4cc8:L (GLU1) to (VAL106) PRE-FUSION STRUCTURE OF TRIMERIC HIV-1 ENVELOPE GLYCOPROTEIN DETERMINED BY CRYO-ELECTRON MICROSCOPY | VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, PRE-FUSION STATE
3csy:F (GLU1) to (ILE106) CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR | GLYCOPROTEIN-ANTIBODY COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3csy:H (GLU1) to (ILE106) CRYSTAL STRUCTURE OF THE TRIMERIC PREFUSION EBOLA VIRUS GLYCOPROTEIN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FROM A HUMAN SURVIVOR | GLYCOPROTEIN-ANTIBODY COMPLEX, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3oau:L (VAL2) to (ILE106) ANTIBODY 2G12 RECOGNIZES DI-MANNOSE EQUIVALENTLY IN DOMAIN- AND NON- DOMAIN-EXCHANGED FORMS, BUT ONLY BINDS THE HIV-1 GLYCAN SHIELD IF DOMAIN-EXCHANGED | FAB, IMMUNE SYSTEM
3d9a:L (ILE2) to (ILE106) HIGH RESOLUTION CRYSTAL STRUCTURE STRUCTURE OF HYHEL10 FAB COMPLEXED TO HEN EGG LYSOZYME | LYSOZYME, HYHEL10, FAB, ANTIBODY, ANTIGEN, ALLERGEN, ANTIMICROBIAL, BACTERIOLYTIC ENZYME, GLYCOSIDASE, HYDROLASE, HYDROLASE-IMMUNE SYSTEM COMPLEX
5ggu:L (ASP1) to (ILE106) CRYSTAL STRUCTURE OF TREMELIMUMAB FAB | ANTIBODY, IMMUNE SYSTEM
3dur:A (VAL3) to (LEU105) CRYSTAL STRUCTURE OF SAG173-04 | ANTIBODY, KDO, TWINNING, PSEUDO-SYMMETRY, IMMUNE SYSTEM
5hcg:L (ILE120) to (ILE224) CRYSTAL STRUCTURE OF FREE-CODV. | CROSS-OVER DUAL VARIABLE IMMUNOGLOBIN, MULTIFUNCTIONAL BIOTHERAPEUTIC FORMAT, BISPECIFIC PROPERTY, CODV, IMMUNE SYSTEM
4dgi:L (ILE2) to (LEU106) STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH HUMAN PRPC FRAGMENT 120- 230 | PRION, ANTIBODY, PROTEIN BINDING
4dgy:L (LEU2) to (ILE106) STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1, C2 FORM | IMMUNOGLOBULIN FOLD, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
3p11:L (ASP1) to (ILE106) ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAINS I-III OF THE HER3 EXTRACELLULAR REGION | BETA-SANDWICH, ANTIGENS HER3, IMMUNE SYSTEM
4dkf:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2 | DIMERIC FOUR-HELIX BUNDLE CYTOKINE, IGG, GLYCOSYLATION, CYTOKINE- IMMUNE SYSTEM COMPLEX
4dkf:M (GLN3) to (ILE106) CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2 | DIMERIC FOUR-HELIX BUNDLE CYTOKINE, IGG, GLYCOSYLATION, CYTOKINE- IMMUNE SYSTEM COMPLEX
5hpm:A (ILE2) to (THR109) CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5hpm:C (ILE2) to (THR109) CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5i15:L (GLN3) to (THR109) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV1-39 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i17:B (PCA1) to (SER118) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV3-20 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i19:L (GLN3) to (ILE106) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV1-39 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i1h:L (GLU1) to (ILE107) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV3-20 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
5i1l:L (ASP1) to (ILE112) CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV4-1 | MONOCLONAL ANTIBODY, IMMUNE SYSTEM
3pjs:A (ASP1) to (ILE108) MECHANISM OF ACTIVATION GATING IN THE FULL-LENGTH KCSA K+ CHANNEL | ION CHANNEL, CONDUCTS K+ IONS, CELL MEMBRANE, TRANSPORT PROTEIN
3pjs:C (ASP1) to (ILE108) MECHANISM OF ACTIVATION GATING IN THE FULL-LENGTH KCSA K+ CHANNEL | ION CHANNEL, CONDUCTS K+ IONS, CELL MEMBRANE, TRANSPORT PROTEIN
5i8c:B (ILE2) to (ILE106) CRYSTAL STRUCTURE OF HIV-1 CLADE A BG505 FUSION PEPTIDE (RESIDUE 512- 520) IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC34.01 FAB | HIV-1, ENVELOPE, TRIMER, FUSION PEPTIDE, ANTIBODY, NEUTRALIZING, IMMUNE SYSTEM
5icx:A (ILE2) to (THR109) CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5icz:A (ILE2) to (THR109) CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5id1:A (ILE2) to (THR109) CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
4ebq:L (VAL4) to (ALA109) FAB STRUCTURE OF ANTI-VACCINIA VIRUS D8L ANTIGEN MOUSE IGG2A LA5 | VARIABLE DOMAIN, CONSTANT DOMAIN, CDR, HYPERVARIABLE REGION, NEUTRALIZING ANTIBODY, VACCINIA VIRUS, D8L ENVELOPE PROTEIN, CONFORMATIONAL EPITOPE, DISCONTINUOUS EPITOPE, D8L ANTIGEN BINDING, NEUTRALIZING MAB IN PRESENCE OF COMPLEMENT, D8L VACCINIA ENVELOPE PROTEIN, PAPAIN TREATMENT, IMMUNE SYSTEM
5iop:A (ILE2) to (THR109) CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
3q3g:C (ILE2) to (LEU112) CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY | IMMUNE SYSTEM-CELL ADHESION COMPLEX
5iv2:A (ILE2) to (THR109) CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT | IMMUNE SYSTEM
4etq:L (VAL4) to (ALA109) VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5 | VARIABLE DOMAIN, CONSTANT DOMAIN, IGG2A, IGG DOMAIN, CDR, HYPERVARIABLE REGION, NEUTRALIZING ANTIBODY, BETA SHEET, CARBONIC ANHYDRASE FOLD, LOOSE KNOT, CHONDROITIN-SULFATE BINDING SITE, DELTA 262, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4etq:B (ILE3) to (ALA109) VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5 | VARIABLE DOMAIN, CONSTANT DOMAIN, IGG2A, IGG DOMAIN, CDR, HYPERVARIABLE REGION, NEUTRALIZING ANTIBODY, BETA SHEET, CARBONIC ANHYDRASE FOLD, LOOSE KNOT, CHONDROITIN-SULFATE BINDING SITE, DELTA 262, IMMUNE SYSTEM-VIRAL PROTEIN COMPLEX
4f2m:D (ILE2) to (LEU106) CRYSTAL STRUCTURE OF A TGEV CORONAVIRUS SPIKE FRAGMENT IN COMPLEX WITH THE TGEV NEUTRALIZING MONOCLONAL ANTIBODY 1AF10 | BETA-BARREL, IMMUNOGLOBULIN, VIRUS ENTRY, VIRUS NEUTRALIZATION, CELLULAR RECEPTOR, AMINOPEPTIDASE N, GLYCOSYLATION, VIRUS MEMBRANE, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
4f3f:A (GLU4) to (ILE106) CRYSTAL STRUCTURE OF MSLN7-64 MORAB-009 FAB COMPLEX | ANTIBODY FAB, RECOGNIZE MESOTHELIN, MESOTHELIN, IMMUNE SYSTEM
4v1d:B (ILE134) to (ILE238) TERNARY COMPLEX AMONG TWO HUMAN DERIVED SINGLE CHAIN ANTIBODY FRAGMENTS AND CN2 TOXIN FROM SCORPION CENTRUROIDES NOXIUS. | TOXIN-IMMUNE SYSTEM COMPLEX, HUMAN SCFV, SCORPION VENOM NEUTRALIZATION, DIRECTED EVOLUTION, CN2 TOXIN.
4ffw:C (GLN1) to (ALA108) CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4, DPP-IV, CD26) IN COMPLEX WITH FAB + SITAGLIPTIN | HYDROLASE, HYDROLASE-IMMUNE SYSTEM, INHIBITOR COMPLEX
3qwo:B (GLN3) to (ILE106) CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB | IMMUNE COMPLEX, IMMUNE SYSTEM
3r1g:L (ASP1) to (THR109) STRUCTURE BASIS OF ALLOSTERIC INHIBITION OF BACE1 BY AN EXOSITE- BINDING ANTIBODY | ASPARTAL PROTEASE, PROTEIN BINDING
4fql:L (GLU1) to (ILE106) INFLUENZA B HA ANTIBODY (FAB) CR8033 | FAB FRAGMENT, MONOCLONAL, VIRAL, IMMUNOGLOBULIN, INFLUENZA B VIRUS, IMMUNE SYSTEM
5jw5:L (ASP1) to (ILE102) STRUCTURE OF MEDI8852 FAB FRAGMENT | ANTIBODY INFLUENZA, IMMUNE SYSTEM
5jw5:B (ASP1) to (ILE102) STRUCTURE OF MEDI8852 FAB FRAGMENT | ANTIBODY INFLUENZA, IMMUNE SYSTEM
4g5z:L (GLU1) to (ILE106) CRYSTAL STRUCTURE OF THE THERAPEUTICAL ANTIBODY FRAGMENT OF CANAKINUMAB IN ITS UNBOUND STATE | IMMUNOGLOBULIN FOLD, ANTIBODY, IMMUNOGLOBULIN, INTERLEUKINE-1BETA BINDING, CYTOKINE, BLOOD SYSTEM, IMMUNE SYSTEM
4g6j:L (VAL3) to (ILE106) CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF CANAKINUMAB | IMMUNGLOBULIN FOLD, INTERLEUKIN-1BETA BINDING, IMMUNE SYSTEM
5k59:L (ILE2) to (ILE106) CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY | TOXIN NEUTRALIZING MONOCLONAL ANTIBODY, CONFORMATIONAL EPITOPE, X-RAY CRYSTAL STRUCTURE, IMMUNE SYSTEM
5k59:F (ILE2) to (ILE106) CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY | TOXIN NEUTRALIZING MONOCLONAL ANTIBODY, CONFORMATIONAL EPITOPE, X-RAY CRYSTAL STRUCTURE, IMMUNE SYSTEM
5kvd:L (ILE2) to (LEU106) ZIKA SPECIFIC ANTIBODY, ZV-2, BOUND TO ZIKA ENVELOPE DIII | ZIKA VIRUS, ENVELOPE DIII, VIRAL PROTEIN, ANTIBODY, IGG2C, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID., VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5kve:L (VAL3) to (ILE106) ZIKA SPECIFIC ANTIBODY, ZV-48, BOUND TO ZIKA ENVELOPE DIII | ZIKA VIRUS, ENVELOPE PROTEIN, VIRAL PROTEIN, SINGLE-CHAIN VARIABLE FRAGMENT, STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS DISEASES, CSGID, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5sx4:I (GLN3) to (ILE106) CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3. | CETUXIMAB, PANITUMUMAB, EGFR, VECTIBIX, ERBITUX, TRANSFERASE-IMMUNE SYSTEM COMPLEX
1nca:L (MET4) to (ILE106) REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX | HYDROLASE(O-GLYCOSYL)
4gw1:A (ILE2) to (THR109) CQFD MEDITOPE | IGG, IMMUNE SYSTEM, EGFR
4hg4:O (ILE2) to (ILE106) CRYSTAL STRUCTURE OF FAB 2G1 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ | VIRAL PROTEIN/IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1bre:B (ILE2) to (ILE106) IMMUNOGLOBULIN LIGHT CHAIN PROTEIN | IMMUNOGLOBULIN
1cic:A (ASP1) to (ILE106) IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225 | IMMUNOGLOBULIN, FAB COMPLEX, IDIOTOPE, ANTI-IDIOTOPE
3sob:L (ILE2) to (ILE106) THE STRUCTURE OF THE FIRST YWTD BETA PROPELLER DOMAIN OF LRP6 IN COMPLEX WITH A FAB | BETA PROPELLER, PROTEIN BINDING-IMMUNE SYSTEM COMPLEX
1p2c:A (ILE2) to (ILE106) CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY | MONOCLONAL ANTIBODY IGG1, KAPPA ANTIBODY/ANTIGEN COMPLEX, IMMUNE SYSTEM/HYDROLASE COMPLEX
1p2c:D (ILE902) to (ILE1006) CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY | MONOCLONAL ANTIBODY IGG1, KAPPA ANTIBODY/ANTIGEN COMPLEX, IMMUNE SYSTEM/HYDROLASE COMPLEX
4xpb:L (VAL3) to (ALA110) X-RAY STRUCTURE OF DROSOPHILA DOPAMINE TRANSPORTER WITH SUBSITEB MUTATIONS (D121G/S426M) BOUND TO COCAINE | INTEGRAL MEMBRANE PROTEIN, ALL-ALPHA HELICAL ANTIDEPRESSANT COMPLEX, TRANPORT PROTEIN-INHIBITOR COMPLEX
4j6r:L (GLU1) to (ILE106) CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC23 IN COMPLEX WITH HIV-1 GP120 | HIV, GP120, CD4-BINDING SITE, VRC23, NEUTRALIZATION, VACCINE, ANTIBODY, ENVELOPE PROTEIN, IMMUNE SYSTEM, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
1efq:A (VAL3) to (ILE106) Q38D MUTANT OF LEN | HUMAN KAPPA-4 IMMUNOGLOBULIN LIGHT CHAIN, MUTANT, MONOMER, URANYL ION IN CRYSTAL CONTACT, ASPARTIC ACID IN BETA-SHEET, PROTEIN STABILITY, IMMUNE SYSTEM
3u46:L (GLU1) to (LEU106) CH04H/CH02L P212121 | IGG, IMMUNOGLOBLULIN, IMMUNE SYSTEM, HIV-1 ANTIBODIES, V1V2-DIRECTED
4yqx:O (ILE5) to (LEU115) MOUSE IL-2 BOUND TO JES6-1 SCFV FRAGMENT | CHEMOKINE, ANTIBODY, COMPLEX, CYTOKINE-IMMUNE SYSTEM COMPLEX
4yxh:L (ILE2) to (LEU106) CRYSTAL STRUCTURE OF DEER PRION PROTEIN COMPLEXED WITH POM1 FAB | PRION, ANTIBODY, IMMUNE SYSTEM COMPLEX, IMMUNE SYSTEM
4yzf:H (ASP1) to (ILE110) CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3 | IMMUNE SYSTEM, HUMAN MEMBRANE PROTEIN, ANION EXCHANGER, ERYTHROCYTES
4yzf:L (ASP1) to (ILE110) CRYSTAL STRUCTURE OF THE ANION EXCHANGER DOMAIN OF HUMAN ERYTHROCYTE BAND 3 | IMMUNE SYSTEM, HUMAN MEMBRANE PROTEIN, ANION EXCHANGER, ERYTHROCYTES
4lmq:L (ASP1) to (THR109) DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12 | IMMUNOGLOBULIN, CELL ADHESION-IMMUNE SYSTEM COMPLEX
3j1s:L (ILE2) to (LYS107) STRUCTURE OF ADENO-ASSOCIATED VIRUS-2 IN COMPLEX WITH NEUTRALIZING MONOCLONAL ANTIBODY A20 | EPITOPE, FAB, GENE THERAPY, VIRUS-IMMUNE SYSTEM COMPLEX
2jix:A (ILE2) to (ILE106) CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR | IMMUNE SYSTEM, RECEPTOR, TRANSMEMBRANE, RECEPTOR SOLUBLE DOMAIN, ANTIBODY, RECEPTOR-IMMUNE SYSTEM COMPLEX
2jix:G (ILE2) to (ILE106) CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR | IMMUNE SYSTEM, RECEPTOR, TRANSMEMBRANE, RECEPTOR SOLUBLE DOMAIN, ANTIBODY, RECEPTOR-IMMUNE SYSTEM COMPLEX
5cd5:D (ASP1) to (ILE108) CRYSTAL STRUCTURE OF AN IMMATURE VRC01-CLASS ANTIBODY DRVIA7 FROM A CHINESE DONOR BOUND TO CLADE A/E HIV-1 GP120 CORE | VRC01, GP120, HIV-1, ANTIBODY, IMMUNE SYSTEM
3juy:A (GLU143) to (ARG249) CRYSTAL STRUCTURE OF A 3B3 VARIANT, A BROADLY NEUTRALIZING HIV-1 SCFV ANTIBODY | HIV, ENVELOPE PROTEIN GP120, BROADLY NEUTRALIZING ANTIBODY, 3B3 SINGLE CHAIN VARIABLE FRAGMENT, IMMUNE SYSTEM
5d71:L (ASP1) to (THR105) CRYSTAL STRUCTURE OF MOR04302, A NEUTRALIZING ANTI-HUMAN GM-CSF ANTIBODY FAB FRAGMENT IN COMPLEX WITH HUMAN GM-CSF | GM-CSF, AFFINITY MATURATION, PHAGE DISPLAY, CYTOKINE, ANTIBODY, PROTEROS BIOSTRUCTURES GMBH, IMMUNE SYSTEM
1yeh:L (ILE2) to (ILE106) STRUCTURE OF IGG2A FAB FRAGMENT | CATALYTIC ANTIBODY, IMMUNOGLOBULIN C REGION
5dqd:L (VAL3) to (ILE106) STRUCTURE OF S55-5 FAB IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE | CARBOHYDRATE BINDING, IMMUNE SYSTEM, ANTIBODY
4py8:J (LEU2) to (ILE106) CRYSTAL STRUCTURE OF FAB 3.1 IN COMPLEX WITH THE 1918 INFLUENZA VIRUS HEMAGGLUTININ | HEMAGGLUTININ GLYCOPROTEINS, IMMUNOGLOBULIN FAB FRAGMENT, MEMBRANE FUSION, NEUTRALIZING ANTIBODIES, VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX
5e2u:L (ASP1) to (VAL111) STRUCTURE OF ANTI-TAU AT8 FAB IN THE PRESENCE OF PHOSPHOPEPTIDE | IMMUNE SYSTEM
5esq:A (ILE2) to (THR109) CETUXIMAB FAB IN COMPLEX WITH CYCLIC BETA-ALANINE-LINKED MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5f3b:B (ASP1) to (ILE106) STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY | MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
5f3b:F (ASP1) to (ILE106) STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY | MYOSTATIN, ANTIBODY, COMPLEX, SIGNALING PROTEIN-IMMUNE SYSTEM COMPLEX
4r97:B (ASP1) to (LEU106) CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF KKO | IMMUNOGLOBULIN, IMMUNE SYSTEM
4d9q:L (ILE2) to (ILE106) INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D | FACTOR D, COMPLEMENT, ANTIBODY, EXOSITE, FAB, CHYMOTRYPSIN, PROTEASE, HYDROLASE-IMMUNE SYSTEM COMPLEX
3or7:B (ILE2) to (ALA109) ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71I | INACTIVATION, ALPHA-HELICAL, POTASSIUM CHANNEL, IMMUNE SYSTEM- TRANSPORT PROTEIN COMPLEX
3duu:C (ILE2) to (LYS106) CRYSTAL STRUCTURE OF SAG506-01, ORTHORHOMBIC, TWINNED, CRYSTAL 2 | ANTIBODY, KDO, TWINNING, PSEUDO-SYMMETRY, IMMUNE SYSTEM
5hdq:L (VAL3) to (ILE106) MNTC CO-STRUCTURE WITH MAB 305-78-7 | TRANSPORT PROTEIN, MONOCLONAL ANTIBODY, TRANSPORT PROTEIN-IMMUNE SYSTEM COMPLEX
4dn4:L (VAL3) to (ILE108) CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CNTO888 FAB AND MCP-1 MUTANT P8A | ANTIBODY CHEMOKINE, IMMUNE SYSTEM
5id0:A (ILE2) to (THR109) CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM
5itf:A (ILE2) to (THR109) CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT | IMMUNE SYSTEM
5ivz:A (LEU3) to (THR109) CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT | IMMUNE SYSTEM
5th2:C (ILE2) to (THR109) CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT | ANTIBODY, ANTI-EGFR, IMMUNE SYSTEM